Jiangsu Yahong Meditech Co., Ltd. (SHA:688176)

China flag China · Delayed Price · Currency is CNY
12.76
+0.03 (0.24%)
Apr 29, 2026, 3:00 PM CST
56.18%
Market Cap 7.29B
Revenue (ttm) 277.12M
Net Income (ttm) -416.38M
Shares Out 571.17M
EPS (ttm) -0.74
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,808,717
Average Volume 13,640,500
Open 12.67
Previous Close 12.73
Day's Range 12.63 - 12.89
52-Week Range 7.65 - 18.11
Beta 0.47
RSI 39.83
Earnings Date Apr 18, 2026

About Jiangsu Yahong Meditech

Jiangsu Yahong Meditech Co., Ltd., a pharmaceutical company, focuses on urogenital tumors and women's health in China and internationally. It develops APL-1702, a photodynamic therapy product for the treatment of high-grade squamous intraepithelial lesions of the cervix, as well as for HPV virus clearance indication; APL-1706 and APLD-2304 for non-muscle invasive bladder cancer (NMIBC) diagnosis and surgery indication; APL-1202, an oral reversible MetAP2 inhibitor for untreated intermediate-risk NMIBC and neoadjuvant therapy before muscle-invas... [Read more]

Sector Healthcare
Founded 2010
Employees 399
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688176
Full Company Profile

Financial Performance

In 2025, Jiangsu Yahong Meditech's revenue was 277.12 million, an increase of 37.49% compared to the previous year's 201.56 million. Losses were -416.38 million, 8.41% more than in 2024.

Financial Statements

News

There is no news available yet.